GlassScriptPhysician profile
Justin Cullers
NPI 1629485248
$2,480.86
in general payments reported to CMS, 2019-2025
24 companies · $589 in 2025
The $589 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $231 · 2022: $723 · 2023: $515 · 2024: $423 · 2025: $589.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,526.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,526.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $381.43 | 2021-2025 | |
| Otsuka America Pharmaceutical, INC. | $354.08 | 2021-2025 | Rexulti |
| Neurocrine Biosciences, INC. | $296.78 | 2021-2025 | |
| Alkermes, INC. | $293.31 | 2021-2025 | Lybalvi |
| E.R. Squibb & Sons, L.L.C. | $194.69 | 2025 | Cobenfy |
| Corium, LLC | $162.10 | 2024-2025 | Azstarys |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $145.78 | 2022-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $108.60 | 2021-2024 | Trintellix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $103.60 | 2023 | |
| Sumitomo Pharma America, INC. | $69.09 | 2024 | |
| Lundbeck LLC | $59.69 | 2022 | |
| Alfasigma USA, INC. | $43.01 | 2021-2022 | |
| Axsome Therapeutics, INC. | $41.14 | 2023-2025 | Auvelity |
| Novo Nordisk INC | $40.00 | 2023 | |
| Bausch Health US, LLC | $34.75 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $27.66 | 2023-2024 | Qelbree, Qelbree |
| Tms Neurohealth Centers INC. | $20.09 | 2025 | Tms Neurohealth Centers INC. |
| Avanir Pharmaceuticals, INC. | $19.23 | 2022 | |
| Sunovion Pharmaceuticals INC. | $16.04 | 2022 | |
| Collegium Pharmaceutical, INC. | $15.27 | 2025 | Jornay Pm |
| Noven Therapeutics, LLC | $14.64 | 2023 | Secuado |
| Vanda Pharmaceuticals INC. | $14.32 | 2025 | Fanapt |
| Ironshore Pharmaceuticals INC. | $13.08 | 2024 | |
| Owp Pharmaceuticals, INC. | $12.48 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Cullers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.